Cantor Fitzgerald Issues Positive Forecast for Hyperliquid Strategies (NASDAQ:PURR) Stock Price

Hyperliquid Strategies (NASDAQ:PURR) had its price objective increased by equities research analysts at Cantor Fitzgerald from $34.30 to $35.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald‘s target price indicates a potential upside of 299.09% from the stock’s current price.

PURR has been the topic of several other reports. Chardan Capital raised their target price on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research note on Friday, August 28th. Wall Street Zen lowered Hyperliquid Strategies from a “hold” rating to a “sell” rating in a research report on Sunday, October 11th. Compass Point started coverage on Hyperliquid Strategies in a report on Monday, September 14th. They issued a “buy” rating and a $18.00 price objective for the company. Finally, Weiss Ratings cut Hyperliquid Strategies from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 23rd. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $20.00.

Hyperliquid Strategies Stock Down 9.5%

Shares of Hyperliquid Strategies stock opened at $8.77 on Friday. The company’s fifty day simple moving average is $11.30 and its two-hundred day simple moving average is $8.02. Hyperliquid Strategies has a 12-month low of $3.01 and a 12-month high of $14.76. The firm has a market cap of $2.44 billion, a PE ratio of -1.37 and a beta of 1.92.

Hyperliquid Strategies (NASDAQ:PURR) last issued its quarterly earnings data on Thursday, November 5th. The company reported $2.54 EPS for the quarter, beating the consensus estimate of $2.10 by $0.44. As a group, sell-side analysts expect that Hyperliquid Strategies will post 2.63 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in PURR. BlackRock Inc. bought a new position in shares of Hyperliquid Strategies in the 2nd quarter worth approximately $79,842,000. Paradigm Operations LP purchased a new position in shares of Hyperliquid Strategies in the 2nd quarter valued at approximately $44,936,535. OLP CAPITAL MANAGEMENT Ltd bought a new stake in shares of Hyperliquid Strategies during the first quarter valued at approximately $10,459,000. Galaxy Digital Inc. bought a new stake in shares of Hyperliquid Strategies during the first quarter valued at approximately $4,581,000. Finally, Wealth High Governance Capital Ltda bought a new stake in shares of Hyperliquid Strategies during the second quarter valued at approximately $6,517,000. 9.45% of the stock is currently owned by institutional investors.

Hyperliquid Strategies News Summary

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Q3 earnings were $2.54 per share, above the $2.10 analyst consensus. The company reported $620.6 million in net income and $13.3 million in revenue. Company financial results
• Positive Sentiment: The company applied to the CFTC to register as a futures commission merchant, aiming to support U.S.-based futures trading. If approved, the move could broaden its market access and business opportunities. CoinDesk article on the U.S. futures platform plan
• Neutral Sentiment: CEO David Schamis said the company deployed $802 million during the quarter and described that investment and the FCM application as linked strategic moves. Company financial results
• Negative Sentiment: Most of the $620.6 million profit came from unrealized gains in HYPE holdings, rather than recurring operating revenue. That makes reported earnings sensitive to token-price swings, while the FCM application still requires regulatory approval. Article on unrealized HYPE gains

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.